Fulminant hepatic failure and paracetamol overuse with therapeutic intent in febrile children

S Sri Ranganathan1, M G Sathiadas, S Sumanasena

  • 1Department of Pharmacology, Faculty of Medicine, University of Colombo, Sri Lanka.

Insights

Overusing paracetamol (acetaminophen) with therapeutic intent in children with fever increases the risk of developing fulminant hepatic failure. This overuse leads to significantly higher paracetamol levels and severe liver injury.

Area of Science:

  • Pediatric Hepatology
  • Clinical Pharmacology
  • Toxicology

Background:

  • Fulminant hepatic failure (FHF) is a rare but severe complication in children.
  • Paracetamol (acetaminophen) is a common antipyretic used in febrile children.
  • Understanding risk factors for FHF is crucial for patient safety.

Purpose of the Study:

  • To investigate the association between paracetamol overuse and FHF in children treated for febrile illnesses.
  • To quantify paracetamol exposure in children who developed FHF.

Main Methods:

  • A case-control study comparing 25 children with FHF to 33 age-matched controls.
  • Assessed paracetamol ingestion history and measured serum paracetamol levels.
  • Evaluated clinical presentation including hepatic encephalopathy grading and liver enzyme levels.

Main Results:

  • All FHF cases consumed supra-therapeutic paracetamol doses (mean 145 mg/kg/day), unlike controls.
  • Mean serum paracetamol levels were significantly higher in cases (26.84 mg/dL) vs. controls (0.051 mg/dL).
  • FHF cases showed higher rates of hepatomegaly, jaundice, and elevated alanine aminotransferase (ALT).

Conclusions:

  • Supra-therapeutic paracetamol dosing is a significant risk factor for FHF in febrile children.
  • This risk is associated with acute viral-like febrile illnesses.
  • Careful monitoring of paracetamol dosage is essential in pediatric fever management.
Abstract

Related Concept Videos

Increased Body Temperature01:25

Increased Body Temperature

A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in response to an infection or illness.
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...